Drugs / LY041001
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00099515 Background | Nov 2004 → Sep 2005 | type 2 diabetes mellitus | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY041001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00099515 ↗ |
| Known as | HIIP | “LY041001 (HIIP)” NCT00099515 ↗ |
| Route | Inhaled | “Inhalation, capsule” NCT00099515 ↗ |